癌症研究
内质网
生物
克拉斯
XBP1型
细胞凋亡
胰腺癌
下调和上调
未折叠蛋白反应
缺氧(环境)
脂肪酸合酶
基因敲除
细胞保护
信号转导
自噬
适应不良
癌症
细胞生物学
热休克蛋白
腺癌
细胞毒性
内分泌学
脂质代谢
脂滴
化学
癌细胞
基因剔除小鼠
医学
间质细胞
PI3K/AKT/mTOR通路
基因沉默
内科学
小RNA
纤维化
作者
Yanqing Jiang,Cassidy Pagen,Gusangyu Yin,Zian Zhang,Mai Wang,Carson D. Poltorack,Yizheng Xue,Xu Han,Nathan J. Coffey,Morgan Brown,Xuanyan Cai,Laura C. Kim,Justin M. Berg,Chih-Hang Anthony Tang,Yihui Shen,Brian Keith,Chih‐Chi Andrew Hu,Marie Celeste Simon
标识
DOI:10.1073/pnas.2612523123
摘要
Pancreatic ductal adenocarcinoma (PDAC) is among the most hypoxic human tumors. Because fatty acid (FA) desaturation is oxygen-dependent, hypoxia can limit monounsaturated FA (MUFA) production, increase membrane lipid saturation, and activate endoplasmic reticulum stress responses, including IRE1α-XBP1s. Here, we found that under oxygen- and MUFA-limiting conditions, spliced XBP1 (XBP1s) is upregulated but unexpectedly exerts a cytotoxic rather than cytoprotective role in PDAC cells. This effect did not differ substantially between classical and basal subtypes. In contrast, pharmacologic or genetic XBP1s inhibition had limited effects on tumor growth and apoptosis in vivo, suggesting this cytotoxicity is largely bypassed by factors in the tumor microenvironment. Consistent with our previous findings that cancer-associated fibroblasts supply unsaturated lipids to tumor cells, subcutaneous tumors showed abundant alpha-smooth muscle actin (α-SMA)-positive stroma, supporting the possibility that stromal lipid supply protects tumors from XBP1s-dependent lipotoxicity. Although XBP1s expression increased during PDAC progression, its distribution remained focal and heterogeneous within human tumors, suggesting spatially restricted IRE1α-XBP1s pathway activation that may limit the efficacy of monotherapy in patients. However, MRTX1133-resistant PDAC became more susceptible to IRE1α-XBP1s targeting, and MRTX1133 acutely activated this pathway in parental cells upon treatment. Importantly, the IRE1α RNase inhibitor B-I09 clearly synergized with MRTX1133 in vitro and in vivo, moreover, this is likely due to MYC-fatty acid synthase (FASN) dysregulation. Together, these findings identify context-dependent vulnerabilities of the IRE1α-XBP1s pathway in PDAC and provide a rationale for combining inhibition of IRE1α and KRAS to enhance therapeutic responses.
科研通智能强力驱动
Strongly Powered by AbleSci AI